ArticleJournal of neuroinflammation2026

Correction: Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury.

Susan A Farr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.